scholarly journals Implications of the recent measurement of pure annihilation Bs→π+π− decays in QCD factorization

2011 ◽  
Vol 702 (5) ◽  
pp. 408-412 ◽  
Author(s):  
Guohuai Zhu
Keyword(s):  
Recent Measurement ◽  
Qcd Factorization

Recent Measurement Technology on Concrete

1991 ◽  
Vol 29 (5) ◽  
pp. 5-14
Author(s):  
Osamu Kiyomiya
Keyword(s):  
Recent Measurement ◽  
Measurement Technology

scholarly journals Assessing recent measurement techniques for quantifying black carbon concentration in snow

2012 ◽  
Vol 5 (3) ◽  
pp. 3771-3795 ◽  
Author(s):  
J. P. Schwarz ◽  
S. J. Doherty ◽  
F. Li ◽  
S. T. Ruggiero ◽  
C. E. Tanner ◽  
...  
Keyword(s):  
Black Carbon ◽  
Single Particle ◽  
Carbon Concentration ◽  
Mass Concentration ◽  
Measurement Techniques ◽  
Integrating Sphere ◽  
Recent Measurement ◽  
Atmospheric Sampling ◽  
Careful Assessment ◽  
Snow Samples

Abstract. We evaluate the performance of the Single Particle Soot Photometer (SP2) and the Integrating Sphere/Integrating Sandwich Spectrophotometer (ISSW) in quantifying the concentration of refractory black carbon (BC) in snow samples. We find that the SP2 can be used to measure BC mass concentration in snow with substantially larger uncertainty (60%) than for atmospheric sampling (<30%). Achieving this level of accuracy requires careful assessment of nebulizer performance and SP2 calibration with consideration of the fact that BC in snow tends to larger sizes than typically observed in the atmosphere. Once these issues are addressed, the SP2 is able to measure the size distribution and mass concentration of BC in the snow. Laboratory comparison of the SP2 and the Integrating Sphere/Integrating Sandwich Spectrophotometer (ISSW) revealed significant biases in the estimate of BC concentration from the ISSW when test samples contained dust or non-absorbing particulates. These results suggest that current estimates of BC mass concentration in snow and ice using either the SP2 or the ISSW may be associated with significant underestimates of uncertainty.

scholarly journals Measurement of the running of the fine structure constant below 1 GeV with the KLOE detector

2019 ◽  
Vol 218 ◽  
pp. 02012
Author(s):  
Graziano Venanzoni
Keyword(s):  
Fine Structure ◽  
Energy Region ◽  
Direct Evidence ◽  
Branching Ratio ◽  
Structure Constant ◽  
Fine Structure Constant ◽  
Recent Measurement ◽  
Single Measurement ◽  
Lepton Universality ◽  
Hadronic Contribution

I will report on the recent measurement of the fine structure constant below 1 GeV with the KLOE detector. It represents the first measurement of the running of α(s) in this energy region. Our results show a more than 5σ significance of the hadronic contribution to the running of α(s), which is the strongest direct evidence both in time-and space-like regions achieved in a single measurement. From a fit of the real part of Δα(s) and assuming the lepton universality the branching ratio BR(ω → µ+µ−) = (6.6 ± 1.4stat ± 1.7syst) · 10−5 has been determined

scholarly journals Constraints on hard spectator scattering and annihilation corrections in B,→PV decays within QCD factorization

2015 ◽  
Vol 743 ◽  
pp. 444-450 ◽  
Author(s):  
Junfeng Sun ◽  
Qin Chang ◽  
Xiaohui Hu ◽  
Yueling Yang
Keyword(s):  
Qcd Factorization

FC 100ASSOCIATION OF SINGLE AND SERIAL MEASURES OF SERUM PHOSPHORUS WITH ADVERSE OUTCOMES IN PATIENTS ON PERITONEAL DIALYSIS: RESULTS FROM THE INTERNATIONAL PDOPPS

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Marcelo Lopes ◽  
Angelo Karaboyas ◽  
David W Johnson ◽  
Talerngsak Kanjanabuch ◽  
Martin Wilkie ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Adverse Outcomes ◽  
Serum Phosphorus ◽  
Target Range ◽  
Recent Measurement ◽  
Baseline Serum ◽  
All Cause Mortality ◽  
Serial Measurements ◽  
Phosphorus Levels

Abstract Background and Aims While it has been established that high serum phosphorus is associated with mortality in hemodialysis (HD) patients, there is limited evidence in the peritoneal dialysis (PD) setting. We evaluated the association of serum phosphorus with mortality and major adverse cardiovascular events (MACE) in patients on PD, and investigated various parameterizations using single and serial measurements of serum phosphorus. Method We utilized data from 7 countries in phase 1 (2014-2017) of the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): Australia, Canada, Japan, New Zealand, Thailand, the UK, and the US. We investigated the association of serum phosphorus and 3 outcomes: all-cause mortality, cardiovascular (CV) mortality, and MACE (CV mortality + non-fatal angina, myocardial infarction, stroke, and heart failure). We parameterized serum phosphorus using 4 different methods: (1) single measurement of baseline serum phosphorus [most recent measurement during 6-month run-in period]; (2) mean serum phosphorus over a 6-month run-in period; (3) number of months (over the past 6 months) with serum phosphorus above the target range (&gt;4.5 mg/dL); (4) mean area-under-the-curve (AUC), calculated as the average amount of time spent with serum phosphorus &gt;4.5 mg/dL multiplied by the extent to which this threshold was exceeded over 6 months. Cox regression was used to estimate the association between each of these 4 exposures with the time-to-event outcomes, in models thoroughly adjusted for possible confounders. Follow-up began after the 6-month run-in period and continued until the outcome occurred, 7 days after leaving the facility due to transfer or change in kidney replacement therapy modality, loss to follow-up, or end of study phase (whichever event occurred first). Results Our sample consisted of 5904 patients who were on PD. Those with higher serum phosphorus levels were younger and had lower hemoglobin levels. Compared to patients with serum phosphorus ≥3.5 to &lt;4.5 mg/dL, we found an all-cause mortality hazard ratio (HR) of 1.62 (95% CI: 1.19, 2.20) for patients with serum phosphorus ≥ 7 mg/dL. Strong associations were also observed using serial phosphorus measures [Table]. For example, compared to the reference group of AUC=0, the HR (95% CI) of death was 1.49 (1.10, 2.00) for AUC &gt;1 to 2; and 1.67 (1.15, 2.41) for AUC &gt;2. Akaike Information Criteria (AIC) results showed that, among the 4 exposures, AUC was the strongest predictor of all-cause mortality, and the single phosphorus measure was the weakest predictor. Associations between serum phosphorus and adverse outcomes were generally stronger for CV death and MACE than for all-cause mortality [Table]. Conclusion As seen in HD patients, this analysis demonstrates that serum phosphorus is a strong predictor of adverse outcomes in patients on PD. When considering serial measurements of serum phosphorus, rates of adverse events began to rise at phosphorus levels &gt;4.5 mg/dL. As recommended by KDIGO guidelines, serial measurements that consider a history of serum phosphorus excursions &gt;4.5 mg/dL should be considered when assessing risks of adverse outcomes.

Sign in / Sign up

Export Citation Format

Share Document